Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Granules Consumer Health serves as Granules’ front-end division for OTC products in the US
The technology is intended to support imaging-based training, protocol optimisation and surgical planning
LYMPHIR addresses a clear clinical need in a disease with limited treatment options
Angelini Ventures has already invested €125 million in 22 startups
The audit was completed with zero critical and zero major observations
Companies in the pharmaceutical industry must shift from L1 (lowest-bid) costing to Life Cycle Cost Analysis (LCCA) to achieve long-term cost optimization, improve decision-making, and enhance sustainability
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
Pharmaplan brings a pan-European footprint of locations and specialist teams, now operating within Exyte’s Biopharma & Life Sciences division
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
Subscribe To Our Newsletter & Stay Updated
